These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32740379)

  • 1. Systemic sclerosis-associated interstitial lung disease.
    Scallan CJ; Collins BF; Raghu G
    Curr Opin Pulm Med; 2020 Sep; 26(5):487-495. PubMed ID: 32740379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial lung disease in systemic sclerosis: current and future treatment.
    Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P
    Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
    Tan A; Denton CP; Mikhailidis DP; Seifalian AM
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
    Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis.
    Hoffmann-Vold AM; Molberg Ø
    Curr Opin Rheumatol; 2020 Nov; 32(6):497-504. PubMed ID: 32890027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
    Cottin V; Brown KK
    Respir Res; 2019 Jan; 20(1):13. PubMed ID: 30658650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of progression in systemic sclerosis patients with interstitial lung disease.
    Distler O; Assassi S; Cottin V; Cutolo M; Danoff SK; Denton CP; Distler JHW; Hoffmann-Vold AM; Johnson SR; Müller Ladner U; Smith V; Volkmann ER; Maher TM
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32079645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease in systemic sclerosis.
    Ostojic P; Cerinic MM; Silver R; Highland K; Damjanov N
    Lung; 2007; 185(4):211-20. PubMed ID: 17717851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview.
    Mackintosh JA; Stainer A; Barnett JL; Renzoni EA
    Semin Respir Crit Care Med; 2019 Apr; 40(2):208-226. PubMed ID: 31137061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and classification of systemic sclerosis-related interstitial lung disease: a review.
    DeMizio DJ; Bernstein EJ
    Curr Opin Rheumatol; 2019 Nov; 31(6):553-560. PubMed ID: 31415029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials].
    Lescoat A; Jouneau S; Uzunhan Y; Jégo P; Cottin V; Hachulla E
    Rev Med Interne; 2022 Jun; 43(6):365-374. PubMed ID: 35181160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary function tests.
    Behr J; Furst DE
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis.
    Molberg Ø; Hoffmann-Vold AM
    Curr Opin Rheumatol; 2016 Nov; 28(6):613-8. PubMed ID: 27387267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Systemic-Sclerosis-Associated Interstitial Lung Disease.
    Silver KC; Silver RM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):439-57. PubMed ID: 26210128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.